Insider Selling: Markel Co. (MKL) Vice Chairman Sells 200 Shares of Stock

Markel Co. (NYSE:MKL) Vice Chairman Steven A. Markel sold 200 shares of the stock in a transaction on Thursday, January 18th. The stock was sold at an average price of $1,109.32, for a total transaction of $221,864.00. Following the sale, the insider now owns 106,560 shares of the company’s stock, valued at $118,209,139.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Shares of Markel Co. (MKL) traded down $0.49 during midday trading on Monday, reaching $1,121.51. 24,977 shares of the company traded hands, compared to its average volume of 42,984. The company has a market capitalization of $15,590.00, a price-to-earnings ratio of 249.78 and a beta of 1.04. Markel Co. has a fifty-two week low of $612.00 and a fifty-two week high of $1,157.30. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.55 and a current ratio of 0.55.

Markel (NYSE:MKL) last issued its earnings results on Wednesday, October 25th. The insurance provider reported ($18.82) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($18.03) by ($0.79). Markel had a return on equity of 0.83% and a net margin of 1.60%. equities analysts anticipate that Markel Co. will post 5.56 EPS for the current year.

Several equities research analysts have recently weighed in on MKL shares. Boenning Scattergood reiterated a “buy” rating on shares of Markel in a research report on Thursday, October 26th. Zacks Investment Research upgraded shares of Markel from a “hold” rating to a “buy” rating and set a $1,253.00 price objective for the company in a research report on Friday, January 5th. SunTrust Banks reiterated a “hold” rating and set a $1,100.00 price objective on shares of Markel in a research report on Friday, October 27th. Finally, Royal Bank of Canada reiterated a “hold” rating and set a $1,050.00 price objective on shares of Markel in a research report on Tuesday, October 3rd. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Markel has an average rating of “Buy” and a consensus price target of $1,109.50.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Ackerman Capital Advisors LLC bought a new position in Markel during the second quarter worth $298,000. Toronto Dominion Bank boosted its stake in Markel by 11.0% during the second quarter. Toronto Dominion Bank now owns 171 shares of the insurance provider’s stock worth $167,000 after acquiring an additional 17 shares in the last quarter. Royal Bank of Canada boosted its stake in Markel by 2.4% during the second quarter. Royal Bank of Canada now owns 28,484 shares of the insurance provider’s stock worth $27,797,000 after acquiring an additional 665 shares in the last quarter. Renaissance Technologies LLC boosted its stake in Markel by 7.9% during the second quarter. Renaissance Technologies LLC now owns 167,577 shares of the insurance provider’s stock worth $163,532,000 after acquiring an additional 12,296 shares in the last quarter. Finally, California Public Employees Retirement System boosted its stake in Markel by 3.4% during the third quarter. California Public Employees Retirement System now owns 29,434 shares of the insurance provider’s stock worth $31,435,000 after acquiring an additional 968 shares in the last quarter. 76.76% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: This story was first published by American Banking News and is owned by of American Banking News. If you are reading this story on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this story can be viewed at https://www.americanbankingnews.com/2018/01/22/insider-selling-markel-co-mkl-vice-chairman-sells-200-shares-of-stock-3.html.

About Markel

Markel Corporation is a financial holding company serving a range of markets. The Company’s principal business markets and underwrites specialty insurance products. It monitors and reports its ongoing underwriting operations in three segments: U.S. Insurance, International Insurance and Reinsurance. The Company, through its subsidiary Markel Ventures, Inc (Markel Ventures), owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace.

Insider Buying and Selling by Quarter for Markel (NYSE:MKL)

Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply